9 June 2015
New research has found that a naturally occurring molecule can help safeguard the body against obesity-related diseases.
The study, conducted by teams at the University of California (UC), San Diego School of Medicine and University College Dublin (UCD), found that this was possible as the molecule worked to reduce inflammation in the fat tissues.
Published in the journal Cell Metabolism, the research focused on liver and kidney diseases, but the researchers believe it could lead to new treatments for a wide range of obesity-fueled conditions.
Co-senior author Dr Kumar Sharma, professor of medicine and director of the Center for Renal Translational Medicine at UC San Diego School of Medicine, said the method essentially boosts the body's natural response for reducing inflammation, and the research shows the benefits of this in obesity-driven diseases.
In the study, the research team focused on a family of lipids, known as specialised pro-resolving mediators (SPMs), which are the body's natural shut-off mechanism for inflammation.
The next step will be to try the method out on human tissue, to see whether it could have an impact on future treatment.
Posted by Edward Bartel
Health News is provided by Adfero in collaboration with Spire Healthcare. Please note that all copy above is ©Adfero Ltd. and does not reflect views or opinions of Spire Healthcare unless explicitly stated. Additional comments on the page from individual Spire consultants do not necessarily reflect the views or opinions of other consultants or Spire Healthcare.